INLIF LIMITED Announces Closing of US$3.75 Million Registered Direct Offering

The financing includes three warrant series, with downward exercise-price resets and additional shares determined by a price-based adjustment.

Rhea-AI Summary

INLIF (Nasdaq: INLF) closed its registered direct offering, receiving approximately US$3.75 million in gross proceeds before fees and expenses.

The company issued 435,000 Class A ordinary shares and pre-funded warrants for up to 1,908,750 shares, each accompanied by Series A, B and C warrants. Package prices were US$1.60 per share or US$1.5999 per pre-funded warrant. Series A and B warrants initially cover up to 2,343,750 shares and 2,343,750 units, respectively. Both have a one-time downward exercise-price reset on the twentieth trading day after closing. Series C warrants provide additional shares through a price-based adjustment over the first ten trading days beginning on issuance.

2 points · 1 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

1 major · 7 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Major pointCompleted offering raised approximately US$3.75 million in gross proceeds before fees and expenses. 11× market cap
• Minor point. Forward-looking: it has not happened yet and may not happen.Planned proceeds deployment includes Phase II manufacturing, equipment, headquarters and R&D investments over the next one to two years.

Negative

• Major point. Forward-looking: it has not happened yet and may not happen.435,000 shares and pre-funded warrants for up to 1,908,750 shares add dilution at US$1.60 and US$1.5999 package prices, respectively.
• Minor point. Forward-looking: it has not happened yet and may not happen.Series A warrants initially cover up to 2,343,750 shares at US$1.60 each, exercisable immediately for five years after closing.
• Minor point. Forward-looking: it has not happened yet and may not happen.Series B warrants initially cover up to 2,343,750 units at US$1.60 each, exercisable immediately until 60 days after issuance.
• Minor point. Forward-looking: it has not happened yet and may not happen.Series B units contain one share or pre-funded warrant and one Series A warrant, adding potential dilution.
• Minor point. Forward-looking: it has not happened yet and may not happen.Series A and B exercise prices face a one-time downward reset on the twentieth trading day after closing.

2 minor points

• Minor point. Forward-looking: it has not happened yet and may not happen.Series C warrants carry a US$0.0001 exercise price; additional shares depend on a first-ten-trading-day price-based adjustment.
• Minor pointPlacement agent, legal, administrative and other offering expenses reduce proceeds available to INLIF.

News Explained

Warrant exercise could add shares beyond the 435,000 issued at closing, while the company received about US$3.75 million gross before expenses.

With the offering closed, the 435,000 ordinary shares issued increase the share count and reduce existing holders’ percentage ownership absent offsetting changes; exercise of the accompanying warrants could add further shares. Series A and B warrants are immediately exercisable at US$1.60; Series A expires five years after closing and Series B 60 days after issuance.

The company says it intends to use net proceeds for its directors and officers and for working-capital purposes, including the Phase II manufacturing facility, equipment, its Xiamen headquarters and R&D platform, new-product research, and recruitment; deployment is expected over one to two years.

Argus 15 min delay 61 alerts

-8.95% vs previous close $0.24 last price 52.9x rel. volume Open Argus

Details

Market move: INLF -8.95% vs previous close. registered direct offering

+15.2% Peak in 10 min

$0.21 – $0.32 Day Range

$259,491 Mkt Cap at Last Price

On Oct 20, the day this news came out, the latest delayed price for INLF is 8.95% below the previous close. Argus tracked a peak move of +15.2% during the session. Our momentum scanner has recorded 61 alerts for this stock so far that day. The latest delayed price is $0.24. Relative volume is exceptionally heavy at 52.9x the average.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

Gross proceeds: Approximately US$3.75 million Class A ordinary shares: 435,000 shares Pre-funded warrants: Up to 1,908,750 ordinary shares +3 more

Gross proceeds

Approximately US$3.75 million

Before placement agent fees and other offering-related expenses

Class A ordinary shares

435,000 shares

Issued at closing of the registered direct offering

Pre-funded warrants

Up to 1,908,750 ordinary shares

Issued as part of the offering

Series A warrants

Up to 2,343,750 ordinary shares

Immediately exercisable at US$1.60 per share; expire five years after closing

Series B warrants

Up to 2,343,750 units

Immediately exercisable at US$1.60 per unit; expire 60 days after issuance

Combined purchase price

US$1.60 per ordinary share or US$1.5999 per pre-funded warrant

Each sold with accompanying Ordinary Warrants

Key Terms

registered direct offering, best-efforts basis, pre-funded warrants, shelf registration statement, +1 more

5 terms

registered direct offering financial

"closing of its previously announced registered direct offering"

A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.

best-efforts basis financial

"offering conducted on a best-efforts basis"

An agreement made on a best-efforts basis means a party promises to try to achieve a result but does not guarantee it. In finance, it often appears in underwriting, placement, or sales arrangements where the seller or intermediary will work to sell securities or complete a transaction using reasonable effort but won’t be liable if full execution fails. Investors care because it affects how certain a deal’s completion and the flow of shares or capital are.

pre-funded warrants financial

"pre-funded warrants to purchase up to 1,908,750 Ordinary Shares"

Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

shelf registration statement regulatory

"made pursuant to the Company’s “shelf” registration statement on Form F-3"

A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.

prospectus supplement regulatory

"A final prospectus supplement and accompanying prospectus describing the terms"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Quanzhou, China, Oct. 20, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (Nasdaq: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced the closing of its previously announced registered direct offering conducted on a best-efforts basis.

The Company issued an aggregate of 435,000 Class A Ordinary Shares, par value of US$0.0001 per share, of the Company (the “Ordinary Shares”), pre-funded warrants to purchase up to 1,908,750 Ordinary Shares (the “Pre-Funded Warrants”), Series A warrants to initially purchase up to 2,343,750 Ordinary Shares (the “Series A Warrants”), Series B warrants to initially purchase up to 2,343,750 units (the “Series B Warrants”, each unit consisting of one Ordinary Share, or one Pre-Funded Warrant in lieu thereof and one Series A Warrant), and Series C warrants to purchase a number of Ordinary Shares to be determined in accordance with their terms (the “Series C Warrants” and, together with the Series A Warrants and the Series B Warrants, the “Ordinary Warrants”), in a registered direct offering (the “Offering”). Each Ordinary Share or Pre-Funded Warrant was sold together with one accompanying Series A Warrant, one accompanying Series B Warrant and one accompanying Series C Warrant at a combined purchase price of US$1.60 per Ordinary Share and accompanying Ordinary Warrants, or US$1.5999 per Pre-Funded Warrant and accompanying Ordinary Warrants, which equals the combined purchase price per Ordinary Share and accompanying Ordinary Warrants minus US$0.0001, the exercise price of each Pre-Funded Warrant.

The Series A Warrants are immediately exercisable at US$1.60 per Ordinary Share and will expire five years after closing. The Series B Warrants are immediately exercisable at US$1.60 per unit and will expire 60 days after issuance. Each of the Series A Warrants and Series B Warrants is subject to a one-time downward exercise price reset on the twentieth trading day after closing along with other adjustments therein. The Series C Warrants will be exercisable at US$0.0001 per share for additional Ordinary Shares determined by a price-based adjustment over the first ten trading days beginning on issuance.

The Company received total gross proceeds of approximately US$3.75 million, prior to deducting placement agent fees, legal fees, administrative and other offering-related expenses. The Company intends to use the net proceeds from the Offering for the Company’s directors and officers and for working capital purposes, including the Phase II manufacturing facility, production and R&D equipment, its Xiamen headquarters and R&D platform, new product R&D (including industrial robots), talent recruitment, and working capital, with deployment expected over the next one to two years.

Maxim Group LLC acted as the sole placement agent for the Offering. Ortoli Rosenstadt LLP acted as U.S. securities counsel to the Company, and Pryor Cashman LLP acted as U.S. securities counsel to the placement agent, in connection with the Offering.

The Offering was made pursuant to the Company’s “shelf” registration statement on Form F-3 (File No. 333-292580), initially filed with the U.S. Securities and Exchange Commission (the “SEC”) on January 5, 2026 and declared effective on January 12, 2026. A final prospectus supplement and accompanying prospectus describing the terms of the Offering have been filed with the SEC and are available on the SEC’s website at www.sec.gov.

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. No offering, sale or solicitation shall be permitted in any jurisdiction where such offering or sale would be unlawful prior to registration, exemption or qualification under the local securities laws of such jurisdiction.

About INLIF LIMITED

INLIF is a holding company and an exempted company incorporated in the Cayman Islands with limited liability. Through its operating entity in the People's Republic of China, Ewatt Robot Equipment Co. Ltd., established in September 2016, INLIF is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. It is also a provider of installation services and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The Company produces an extensive portfolio of injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms, all developed by itself. It has also built experience in industrial automation solutions, including in the new energy sector, as well as intelligent robotics in recent years. For more information, please visit the Company's website: https://ir.yiwate88.com/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions, and includes such statements regarding timing of closing, satisfaction of closing conditions, and expected proceeds from the offering. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. 

These forward-looking statements are subject to substantial risks and uncertainties that may cause actual results, performance or achievements to differ materially from those expressed or implied, including without limitation: the Company’s ability to complete the Offering in accordance with the expected timeline and terms; satisfaction of closing conditions; the planned use and actual deployment of net proceeds; adverse changes in global market conditions and capital market sentiment; risks relating to the Company’s business strategy adjustment and asset optimization;  the ability to maintain the Company’s Nasdaq listing status; changes in industry policies and regulatory rules; future capital financing needs; and other risk factors disclosed in the Company’s periodic filings and subsequent submissions with the SEC, including its Annual Report on Form 20-F. 

Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the U.S. Securities and Exchange Commission.

Contact

INLIF LIMITED
Investor Relations Department
Email: ir@yiwate88.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did INLIF raise in its registered direct offering, and at what price?

INLIF received approximately US$3.75 million in gross proceeds before fees and expenses. Each share-and-warrants package cost US$1.60, while each pre-funded-warrant package cost US$1.5999. Each package included Series A, B and C warrants; the pre-funded warrants have a US$0.0001 exercise price.

How does INLIF plan to use the offering proceeds?

INLIF intends to use net proceeds for its directors and officers and working capital purposes, with deployment expected over the next one to two years. Planned uses include the Phase II manufacturing facility, production and R&D equipment, the Xiamen headquarters and R&D platform, new product R&D including industrial robots, and talent recruitment.